Cargando…
Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma
BACKGROUND: Metastasis occurs in the majority of pancreatic ductal adenocarcinoma (PDAC) patients at diagnosis or following resection. Patients with liver metastasis and those with lung metastasis have significantly different prognosis. Here, we sought to understand how cancer-associated fibroblasts...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561960/ https://www.ncbi.nlm.nih.gov/pubmed/34727952 http://dx.doi.org/10.1186/s13045-021-01203-1 |
_version_ | 1784593173373255680 |
---|---|
author | Pan, Xingyi Zhou, Jiaojiao Xiao, Qian Fujiwara, Kenji Zhang, Mengwen Mo, Guanglan Gong, Wei Zheng, Lei |
author_facet | Pan, Xingyi Zhou, Jiaojiao Xiao, Qian Fujiwara, Kenji Zhang, Mengwen Mo, Guanglan Gong, Wei Zheng, Lei |
author_sort | Pan, Xingyi |
collection | PubMed |
description | BACKGROUND: Metastasis occurs in the majority of pancreatic ductal adenocarcinoma (PDAC) patients at diagnosis or following resection. Patients with liver metastasis and those with lung metastasis have significantly different prognosis. Here, we sought to understand how cancer-associated fibroblasts (CAFs) play roles in the development of organ-specific metastasis. METHODS: PDAC tumor cell lines established from the primary tumors with liver and lung metastasis potentials, respectively, in Kras/p53 mutation conditional knock-in (KPC) mice were co-cultured with matched CAFs or mouse mesenchymal stem cells. CAFs were isolated from metastases and subjected to DNA methylation and whole transcriptomic RNA sequencing analysis. RESULTS: The ability of mouse PDAC tumor cell lines in developing liver or lung-specific metastases was demonstrated in orthotopic models. Tumor cells associated with liver metastasis potential, but not those associated with lung metastasis potential, induced the methylation of metabolism genes including NQO1 and ALDH1a3 and subsequent downregulated mRNA expression of a broader group of metabolism genes in CAFs. DNA methylation and downregulation of metabolism genes in CAFs in liver metastasis, but not those in lung metastasis, appeared to be regulated by DNA methyltransferase. Tumor cells associated with liver metastasis potential, but not those associated with lung metastasis potential, induce inflammatory CAF (iCAF) signatures. CAFs from liver metastasis demonstrated a more homogenous iCAF phenotype, whereas CAFs from lung metastasis maintained the heterogeneity. CONCLUSIONS: PDAC with organ-specific metastatic potentials has different capacities in inducing methylation of metabolism genes in CAFs, modulating CAF phenotypes, and resulting in different levels of heterogeneity of CAFs in different metastatic niches. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13045-021-01203-1. |
format | Online Article Text |
id | pubmed-8561960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85619602021-11-03 Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma Pan, Xingyi Zhou, Jiaojiao Xiao, Qian Fujiwara, Kenji Zhang, Mengwen Mo, Guanglan Gong, Wei Zheng, Lei J Hematol Oncol Letter to the Editor BACKGROUND: Metastasis occurs in the majority of pancreatic ductal adenocarcinoma (PDAC) patients at diagnosis or following resection. Patients with liver metastasis and those with lung metastasis have significantly different prognosis. Here, we sought to understand how cancer-associated fibroblasts (CAFs) play roles in the development of organ-specific metastasis. METHODS: PDAC tumor cell lines established from the primary tumors with liver and lung metastasis potentials, respectively, in Kras/p53 mutation conditional knock-in (KPC) mice were co-cultured with matched CAFs or mouse mesenchymal stem cells. CAFs were isolated from metastases and subjected to DNA methylation and whole transcriptomic RNA sequencing analysis. RESULTS: The ability of mouse PDAC tumor cell lines in developing liver or lung-specific metastases was demonstrated in orthotopic models. Tumor cells associated with liver metastasis potential, but not those associated with lung metastasis potential, induced the methylation of metabolism genes including NQO1 and ALDH1a3 and subsequent downregulated mRNA expression of a broader group of metabolism genes in CAFs. DNA methylation and downregulation of metabolism genes in CAFs in liver metastasis, but not those in lung metastasis, appeared to be regulated by DNA methyltransferase. Tumor cells associated with liver metastasis potential, but not those associated with lung metastasis potential, induce inflammatory CAF (iCAF) signatures. CAFs from liver metastasis demonstrated a more homogenous iCAF phenotype, whereas CAFs from lung metastasis maintained the heterogeneity. CONCLUSIONS: PDAC with organ-specific metastatic potentials has different capacities in inducing methylation of metabolism genes in CAFs, modulating CAF phenotypes, and resulting in different levels of heterogeneity of CAFs in different metastatic niches. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13045-021-01203-1. BioMed Central 2021-11-02 /pmc/articles/PMC8561960/ /pubmed/34727952 http://dx.doi.org/10.1186/s13045-021-01203-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Pan, Xingyi Zhou, Jiaojiao Xiao, Qian Fujiwara, Kenji Zhang, Mengwen Mo, Guanglan Gong, Wei Zheng, Lei Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma |
title | Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma |
title_full | Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma |
title_fullStr | Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma |
title_full_unstemmed | Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma |
title_short | Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma |
title_sort | cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561960/ https://www.ncbi.nlm.nih.gov/pubmed/34727952 http://dx.doi.org/10.1186/s13045-021-01203-1 |
work_keys_str_mv | AT panxingyi cancerassociatedfibroblastheterogeneityisassociatedwithorganspecificmetastasisinpancreaticductaladenocarcinoma AT zhoujiaojiao cancerassociatedfibroblastheterogeneityisassociatedwithorganspecificmetastasisinpancreaticductaladenocarcinoma AT xiaoqian cancerassociatedfibroblastheterogeneityisassociatedwithorganspecificmetastasisinpancreaticductaladenocarcinoma AT fujiwarakenji cancerassociatedfibroblastheterogeneityisassociatedwithorganspecificmetastasisinpancreaticductaladenocarcinoma AT zhangmengwen cancerassociatedfibroblastheterogeneityisassociatedwithorganspecificmetastasisinpancreaticductaladenocarcinoma AT moguanglan cancerassociatedfibroblastheterogeneityisassociatedwithorganspecificmetastasisinpancreaticductaladenocarcinoma AT gongwei cancerassociatedfibroblastheterogeneityisassociatedwithorganspecificmetastasisinpancreaticductaladenocarcinoma AT zhenglei cancerassociatedfibroblastheterogeneityisassociatedwithorganspecificmetastasisinpancreaticductaladenocarcinoma |